Umit Kervan, President of Tüseb, said at the introductory meeting of the domestic heart-lung machine, which was developed in cooperation with Tüseb and Aselsan on the Bilkent Campus, which is to be carried out openly and successfully for operations in the Idea Laboratories under the roof of Tüseb.
Kemal Memişoğlu, Chairman of the Board of Directors of the Health Minister Kemal Memişoğlu'nun Tüseb, is an institute within the Ministry in which Kervan, Tüseb said that 9 institutes said.
Caravan, Cancer, Vaccination Institute, Institute for Health Policy of the Artificial Intelligence Institute, such as the President of each institute of professional professors who are experts in this area, in the past 8 months the teams have made great efforts to examine their own subjects.
With the doubles of the institution's budget, 70 percent of this budget supports the project, which is expressed that the goals, f & e and innovations in the field of health and the development of future technologies were added.
In this context, it is very valuable that the cardiovascular machine is very valuable, said Kervan: “As Tüseb, it is our goal to write success stories with the private sector that works at the universities and in the health sector in Türkiye. We are to ced with the ability of every structure in these success stories.
“The results are better than other devices”
Kervan said that in 2020 there was a consensus to develop a cardiovascular machine with Aselsan.
“Our engineering friends in Aselsan have come into our operating theaters. Each of the operating theaters with open cardiovascular rooms. They consulted with heart surgeons who used this machine and made an open cardiovascular operation.
The device's laboratory work was carried out in the Bilkent City Hospital, said the Kervan: “The results of the cardiovascular machine we did with Aselsan were even better than other devices.” he said.
Kervan reported that the device developed by Aselsan has received 3 awards with its design and construction technology without starting animal work.
“In Torkiye, surgery is carried out annually with an operation of 80,000 thousand” annually “
Kervan emphasizes that working in Tüseb animal laboratories in Istanbul is very successful: “With this success, the next step is to use the cardiovascular machine in clinical studies. This device is a valuable and very strategic product for us.
Around 300 operations for open heart in Torkiye, which points out that the center of Kervan said:
“Each of them has about 2 to 4 operating theaters. Every operating room is used in these devices. We hope that in 2026 we developed the cardiovascular machines that we developed with Aselsan in our own operating rooms in hospitals in the Türkiye. We are sure that we have developed a device with high international competition. We will develop new generations in the world.
“The manufacturer of the world ailment machine in the world is no more than 3”
He explained that he was a heart surgeon, the caravan, the first medical director of the machine, he said.
Kervan pointed out that a product in which the ideas of scientists in Türkiye came together, said:
“This process took about 2 years. It is a great success to get into this phase in the period of around 5 years. A progressive technology has been completed in 5 years. Clinical work has come into the phase of work. This is a great success. The number of manufacturers of the heart tung machine in the world is no more than 3. It is a product that requires an advanced technology this year.”
“We opened a large animal laboratory in Istanbul”
Kervan found that there are laboratory studies in which small animal experiments can be carried out in Torkiye, and pointed out that such large systems and devices can be tested to carry out tests and pointed out that great money was spent.
Kervan recalled that a large animal laboratory was opened in Istanbul and continued his words as follows:
“Now sheep is being tested in pigs, much larger animals in medical devices. These tests have in the long term. We have three operating theaters. We have Angiografabor. We have set up a robot surgery center. We make a laboratory for 7 days. You have led you to increase the international competition of our domestic manufacturer.
Kervan underlines that the economic return of the device will be very large. “The number of heart centers in Türkiye is very high. There are a number of heart centers in Germany in Germany. We are also 300 and the health service is very upper limit. Health tourism comes to our patient. Cardiovascular machine has a budget of around 3 billion dollars.
Bir yanıt yazın